{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T05:42:02Z","timestamp":1794634922527,"version":"4.9.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["M4\/C2\/L3.1.1"],"award-info":[{"award-number":["M4\/C2\/L3.1.1"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ejmech.2025.117562","type":"journal-article","created":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T04:35:24Z","timestamp":1742790924000},"page":"117562","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Exploring Si-phthalocyanines with different valency for PSMA-targeted photodynamic therapy: Synthesis and preclinical validation"],"prefix":"10.1016","volume":"290","author":[{"given":"Valentina","family":"Dinatale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9125-8004","authenticated-orcid":false,"given":"Martina","family":"Capozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachele","family":"Stefania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Liuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henriette S.","family":"de Bruijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roisin","family":"McMorrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Zambito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Mezzanotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enzo","family":"Terreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejmech.2025.117562_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-020-00243-0","article-title":"Prostate cancer","volume":"7","author":"Rebello","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"12","key":"10.1016\/j.ejmech.2025.117562_bib2","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/jnci\/90.12.889","article-title":"Photodynamic therapy","volume":"90","author":"Dougherty","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"issue":"5","key":"10.1016\/j.ejmech.2025.117562_bib3","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nrc1071","article-title":"Photodynamic therapy for cancer","volume":"3","author":"Dolmans","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.ejmech.2025.117562_bib4","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1634\/theoncologist.11-9-1034","article-title":"Photodynamic therapy in oncology","volume":"11","author":"Triesscheijn","year":"2006","journal-title":"Oncologist"},{"issue":"5","key":"10.1016\/j.ejmech.2025.117562_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16050967","article-title":"Photodynamic therapy and adaptive immunity induced by reactive oxygen species: recent reports","volume":"16","author":"Aebisher","year":"2024","journal-title":"Cancers"},{"issue":"17","key":"10.1016\/j.ejmech.2025.117562_bib6","doi-asserted-by":"crossref","first-page":"6932","DOI":"10.1158\/0008-5472.CAN-09-1682","article-title":"Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer","volume":"69","author":"Hillier","year":"2009","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.ejmech.2025.117562_bib7","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.taap.2007.01.025","article-title":"Photodynamic therapy with the phthalocyanine photosensitizer Pc 4: the case experience with preclinical mechanistic and early clinical-translational studies","volume":"224","author":"Miller","year":"2007","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"10","key":"10.1016\/j.ejmech.2025.117562_bib8","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/lsm.20984","article-title":"Silicon phthalocyanine (Pc 4) photodynamic therapy is a safe modality for cutaneous neoplasms: results of a phase 1 clinical trial","volume":"42","author":"Baron","year":"2010","journal-title":"Laser Surg. Med."},{"key":"10.1016\/j.ejmech.2025.117562_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2019.105575","article-title":"Zinc(II) phthalocyanines as photosensitizers for antitumor photodynamic therapy","volume":"114","author":"Roguin","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ejmech.2025.117562_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.980239","article-title":"Photodynamic therapy for prostate cancer: recent advances, challenges and opportunities","volume":"12","author":"Xue","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejmech.2025.117562_bib11","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/896161","article-title":"Photodynamic therapy with the silicon phthalocyanine pc 4 induces apoptosis in mycosis fungoides and sezary syndrome","volume":"2010","author":"Lam","year":"2010","journal-title":"Adv Hematol"},{"issue":"9","key":"10.1016\/j.ejmech.2025.117562_bib12","doi-asserted-by":"crossref","first-page":"916","DOI":"10.7150\/thno.4571","article-title":"Unique diagnostic and therapeutic roles of porphyrins and phthalocyanines in photodynamic therapy, imaging and theranostics","volume":"2","author":"Josefsen","year":"2012","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.ejmech.2025.117562_bib13","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.7150\/thno.52166","article-title":"Photosensitizer-based multimodal PSMA-targeting ligands for intraoperative detection of prostate cancer","volume":"11","author":"Derks","year":"2021","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117562_bib14","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1158\/0008-5472.CAN-19-0201","article-title":"Photodynamic therapy is an effective adjuvant therapy for image-guided surgery in prostate cancer","volume":"80","author":"Wang","year":"2020","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.ejmech.2025.117562_bib15","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1007\/s00259-023-06224-1","article-title":"Imaging and photodynamic therapy of prostate cancer using a theranostic PSMA-targeting ligand","volume":"50","author":"Derks","year":"2023","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"issue":"11","key":"10.1016\/j.ejmech.2025.117562_bib16","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1158\/1078-0432.CCR-04-2690","article-title":"Radiolabeled small-molecule ligands for prostate-specific membrane antigen: in vivo imaging in experimental models of prostate cancer","volume":"11","author":"Foss","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.ejmech.2025.117562_bib17","doi-asserted-by":"crossref","first-page":"914","DOI":"10.2967\/jnumed.114.147413","article-title":"Preclinical evaluation of a tailor-made DOTA-conjugated PSMA inhibitor with optimized linker moiety for imaging and endoradiotherapy of prostate cancer","volume":"56","author":"Bene\u0161ov\u00e1","year":"2015","journal-title":"J. Nucl. Med."},{"issue":"2","key":"10.1016\/j.ejmech.2025.117562_bib18","doi-asserted-by":"crossref","first-page":"310","DOI":"10.7150\/jca.22362","article-title":"Potent peptide-conjugated silicon phthalocyanines for tumor photodynamic therapy","volume":"9","author":"Liu","year":"2018","journal-title":"J. Cancer"},{"issue":"8","key":"10.1016\/j.ejmech.2025.117562_bib19","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1158\/1535-7163.MCT-15-0722","article-title":"Theranostic agents for photodynamic therapy of prostate cancer by targeting prostate-specific membrane antigen","volume":"15","author":"Wang","year":"2016","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejmech.2025.117562_bib20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jphotobiol.2016.12.018","article-title":"A PSMA-targeted theranostic agent for photodynamic therapy","volume":"167","author":"Chen","year":"2017","journal-title":"J. Photochem. Photobiol., B"},{"issue":"21","key":"10.1016\/j.ejmech.2025.117562_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112878","article-title":"A novel PSMA-targeted probe for NIRF-guided surgery and photodynamic therapy: synthesis and preclinical validation","volume":"23","author":"Capozza","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.ejmech.2025.117562_bib22","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.7150\/thno.13448","article-title":"Design of internalizing PSMA-specific glu-ureido-based radiotherapeuticals","volume":"6","author":"W\u00fcstemann","year":"2016","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117562_bib23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2967\/jnumed.118.212720","article-title":"Synthesis and preclinical characterization of the PSMA-targeted hybrid tracer PSMA-I&F for nuclear and fluorescence imaging of prostate cancer","volume":"60","author":"Schottelius","year":"2019","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejmech.2025.117562_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202400218","article-title":"Silicon phthalocyanines functionalized with axial substituents targeting PSMA: synthesis and preliminary assessment of their potential for PhotoDynamic Therapy of prostate cancer","author":"Capozza","year":"2024","journal-title":"ChemMedChem"},{"issue":"5","key":"10.1016\/j.ejmech.2025.117562_bib25","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s12551-023-01129-7","article-title":"Phthalocyanine aggregates in the photodynamic therapy: dogmas, controversies, and future prospects","volume":"15","author":"Bunin","year":"2023","journal-title":"Biophys. Rev."},{"issue":"4","key":"10.1016\/j.ejmech.2025.117562_bib26","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00418-003-0566-8","article-title":"Mitochondrial localization of reactive oxygen species by dihydrofluorescein probes","volume":"120","author":"Diaz","year":"2003","journal-title":"Histochem. Cell Biol."},{"issue":"4","key":"10.1016\/j.ejmech.2025.117562_bib27","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s00268-005-0544-5","article-title":"Expression of prostate-specific membrane antigen in normal and malignant human tissues","volume":"30","author":"Kinoshita","year":"2006","journal-title":"World J. Surg."},{"key":"10.1016\/j.ejmech.2025.117562_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.764137","article-title":"Synthesis and applications of porphyrin-biomacromolecule conjugates","volume":"9","author":"Pathak","year":"2021","journal-title":"Front. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117562_bib29","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1021\/acs.jmedchem.0c01735","article-title":"Synthesis, tumor specificity, and photosensitizing efficacy of erlotinib-conjugated chlorins and bacteriochlorins: identification of a highly effective candidate for photodynamic therapy of cancer","volume":"64","author":"Cheruku","year":"2021","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2025.117562_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/nano8110923","article-title":"Nano-mediated photodynamic therapy for cancer: enhancement of cancer specificity and therapeutic effects","volume":"8","author":"Mfouo Tynga","year":"2018","journal-title":"Nanomaterials (Basel)"},{"issue":"8","key":"10.1016\/j.ejmech.2025.117562_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15082124","article-title":"Photosensitizers-loaded nanocarriers for enhancement of photodynamic therapy in melanoma treatment","volume":"15","author":"Udrea","year":"2023","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117562_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14020322","article-title":"Synergic antitumor effect of photodynamic therapy and chemotherapy mediated by nano drug delivery systems","volume":"14","author":"Aghajanzadeh","year":"2022","journal-title":"Pharmaceutics"},{"issue":"24","key":"10.1016\/j.ejmech.2025.117562_bib33","doi-asserted-by":"crossref","first-page":"13135","DOI":"10.1021\/acs.chemrev.0c00663","article-title":"Visible-to-NIR-Light activated release: from small molecules to nanomaterials","volume":"120","author":"Weinstain","year":"2020","journal-title":"Chem. Rev."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117562_bib34","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41392-022-00906-2","article-title":"Asymmetric, amphiphilic RGD conjugated phthalocyanine for targeted photodynamic therapy of triple negative breast cancer","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1091","key":"10.1016\/j.ejmech.2025.117562_bib35","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20170893","article-title":"Recent advances in theranostics and challenges for the future","volume":"91","author":"Turner","year":"2018","journal-title":"Br. J. Radiol."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117562_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12010190","article-title":"In-vivo optical monitoring of the efficacy of epidermal growth factor receptor targeted photodynamic therapy: the effect of fluence rate","volume":"12","author":"Peng","year":"2020","journal-title":"Cancers"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425003277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425003277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T14:08:46Z","timestamp":1762265326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425003277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":36,"alternative-id":["S0223523425003277"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117562","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring Si-phthalocyanines with different valency for PSMA-targeted photodynamic therapy: Synthesis and preclinical validation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117562","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117562"}}